MondegarAI
← Tracker

Institutional

HARBOURVEST PARTNERS LLC

CIK 0001201001
$100.9M
Reported AUM
5
Positions
Q1 2026
Period
2026-05-15
Filed

The Brief · HARBOURVEST PARTNERS LLC · Q1 2026

AI · grounded in 13F

HARBOURVEST PARTNERS LLC established a new position in Generate Biomedicines GENB valued at $21.5M. The fund closed three positions, most notably exiting Rubrik, Inc. RBRK for $6.9M. Other liquidated holdings included Epsilon Energy LTD EPSN at $3.9M and Repare Therapeutics, Inc. RPTX at $31.9K.

Portfolio · Q1 2026

KLAR$65.8MGENB$21.5MYMM$7.9MCAMP$5.6MHL

Top holdings

QoQ vs Q4 2025

#StockIssuerPriceDay %1Y Gr.5Y Gr.Value% of bookΔ shares (QoQ)Status
1KLARKlarna Group PLC$16.732.26%-61.88%-56.45%$65.8M65.17%HELD
2GENBGenerate Biomedicines$12.87-12.45%1.74%2.96%$21.5M21.33%+1,722,210NEW
3YMMFull Truck Alliance Co. Ltd.$8.59-3.16%-28.45%-5.74%$7.9M7.88%HELD
4CAMPCAMP4 Therapeutics Corp$4.202.31%114.06%-14.20%$5.6M5.56%HELD
5IPSCCentury Therapeutics, Inc.$2.13-3.18%245.78%-92.69%$66K0.06%HELD
6RBRKRubrik, Inc.$73.41-4.66%-25.02%140.85%90,271EXITED
7EPSNEpsilon Energy LTD$5.79-2.36%-18.20%37.78%840,598EXITED
8RPTXRepare Therapeutics, Inc.12,276EXITED

Source: SEC EDGAR · accession 0001193125-26-225130. 13F discloses long positions only — shorts, foreign equities, and options are excluded.